ReNeuron Group Plc Share Price London S.E.
Equities
Biotechnology & Medical Research
Sales 2022 | 403K 505K 42.13M | Sales 2023 | 530K 664K 55.41M | Capitalization | 5.17M 6.48M 541M |
---|---|---|---|---|---|
Net income 2022 | -9M -11.27M -941M | Net income 2023 | -5M -6.26M -523M | EV / Sales 2022 | 8.48 x |
Net cash position 2022 | 13.99M 17.51M 1.46B | Net cash position 2023 | 6.73M 8.43M 704M | EV / Sales 2023 | -2.94 x |
P/E ratio 2022 |
-1.79
x | P/E ratio 2023 |
-0.96
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 78.26% |
Latest transcript on ReNeuron Group Plc
Managers | Title | Age | Since |
---|---|---|---|
Suzanne Hancock
COO | Chief Operating Officer | - | 01/17/01 |
Chief Tech/Sci/R&D Officer | - | 03/22/03 | |
Simon Dew
PRN | Corporate Officer/Principal | - | 01/22/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Martin Walton
BRD | Director/Board Member | 61 | 22/22/22 |
Iain Ross
CHM | Chairman | 71 | 01/21/01 |
Director/Board Member | 61 | 14/21/14 |
1st Jan change | Capi. | |
---|---|---|
+17.96% | 44.96B | |
+1.17% | 42.65B | |
+48.77% | 41.85B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |